Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy using bone marrow transplantation: a 1990 update.

P M Lehn1

  • 1BMT Unit, Hospital Saint-Louis, Paris, France.

Bone Marrow Transplantation
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gene therapy in onco-hematology. Perspectives and ethics].

Soins; la revue de reference infirmiere·1990
Same author

Gene therapy using bone marrow transplantation.

Bone marrow transplantation·1987
See all related articles

Recombinant retroviruses show promise for gene transfer into hematopoietic stem cells. While early in vivo studies were disappointing, recent advancements in vectors and cell lines have improved gene expression in mice.

Area of Science:

  • Gene therapy
  • Hematopoietic stem cell research
  • Retroviral vector development

Background:

  • Gene transfer into hematopoietic tissue in vivo using recombinant retroviruses is an emerging field.
  • Initial in vitro studies showed exciting potential, but early in vivo studies in mice yielded disappointing results with transient and low gene expression.
  • Recent progress in murine models has shown improved gene transfer efficiency and expression.

Purpose of the Study:

  • To review the progress and challenges of using recombinant retroviruses for gene transfer into hematopoietic stem cells in vivo.
  • To highlight recent advancements in vector design and packaging cell lines.
  • To identify key areas for future research to improve gene transfer efficacy in large animals.

Main Methods:

Related Experiment Videos

  • Review of recent literature on retroviral vector development for hematopoietic stem cell gene transfer.
  • Analysis of in vitro and in vivo study results in murine and large animal models.
  • Discussion of strategies for enhancing gene expression and safety.

    • Main Results:

    • Significant improvements in gene expression levels have been achieved in long-term murine transplant recipients.
    • Newer, safer, and efficient packaging cell lines have been developed.
    • Gene transfer into hematopoietic stem cells in large animals remains challenging and disappointing.

    Conclusions:

    • Further progress in hematopoietic stem cell gene therapy requires a strategic approach.
    • Key areas for advancement include understanding gene function, designing optimized vectors with proper regulation, and characterizing target cell properties.
    • Bridging the gap between murine model success and large animal application is crucial for clinical translation.